Logo image of EMF

TEMPLETON EMERGING MARKETS (EMF) Stock Overview

USA - NYSE:EMF - US8801911012

16.41 USD
-0.61 (-3.58%)
Last: 10/10/2025, 9:23:03 PM
Fundamental Rating

3

Taking everything into account, EMF scores 3 out of 10 in our fundamental rating. EMF was compared to 0 industry peers in the Unkown industry. The financial health of EMF is average, but there are quite some concerns on its profitability. EMF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EMF was profitable.
In the past year EMF had a positive cash flow from operations.
EMF had positive earnings in 4 of the past 5 years.
EMF had a positive operating cash flow in 4 of the past 5 years.
EMF Yearly Net Income VS EBIT VS OCF VS FCFEMF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA 13.19%
ROE 13.66%
ROIC 1.4%
ROA(3y)-5.09%
ROA(5y)2.7%
ROE(3y)-6.26%
ROE(5y)2.34%
ROIC(3y)1.66%
ROIC(5y)1.2%
EMF Yearly ROA, ROE, ROICEMF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

EMF's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of EMF has grown nicely.
EMF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 56.73%
PM (TTM) 424.27%
GM 58.67%
OM growth 3Y31.34%
OM growth 5Y5.57%
PM growth 3Y-20.37%
PM growth 5YN/A
GM growth 3Y28.08%
GM growth 5Y5.26%
EMF Yearly Profit, Operating, Gross MarginsEMF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, EMF has less shares outstanding
The number of shares outstanding for EMF has been reduced compared to 5 years ago.
EMF has a better debt/assets ratio than last year.
EMF Yearly Shares OutstandingEMF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EMF Yearly Total Debt VS Total AssetsEMF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EMF has an Altman-Z score of 20.67. This indicates that EMF is financially healthy and has little risk of bankruptcy at the moment.
EMF has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
A Debt/Equity ratio of 0.02 indicates that EMF is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for EMF, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 20.67
ROIC/WACCN/A
WACCN/A
EMF Yearly LT Debt VS Equity VS FCFEMF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

EMF has a Current Ratio of 2.87. This indicates that EMF is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.87 indicates that EMF has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.87
EMF Yearly Current Assets VS Current LiabilitesEMF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.96% over the past year.
The earnings per share for EMF have been decreasing by -15.17% on average. This is quite bad
Looking at the last year, EMF shows a decrease in Revenue. The Revenue has decreased by -6.25% in the last year.
The Revenue has been decreasing by -1.10% on average over the past years.
EPS 1Y (TTM)87.96%
EPS 3Y-15.17%
EPS 5YN/A
EPS Q2Q%26.67%
Revenue 1Y (TTM)-6.25%
Revenue growth 3Y4.04%
Revenue growth 5Y-1.1%
Sales Q2Q%-8.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMF Yearly Revenue VS EstimatesEMF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.08, which indicates a very decent valuation of EMF.
Compared to an average S&P500 Price/Earnings ratio of 27.02, EMF is valued rather cheaply.
Industry RankSector Rank
PE 8.08
Fwd PE N/A
EMF Price Earnings VS Forward Price EarningsEMF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 8.06
EV/EBITDA N/A
EMF Per share dataEMF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

EMF has a Yearly Dividend Yield of 6.94%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.44, EMF pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.94%

5.2 History

The dividend of EMF decreases each year by -1.59%.
EMF has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-1.59%
Div Incr Years0
Div Non Decr Years0
EMF Yearly Dividends per shareEMF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

25.40% of the earnings are spent on dividend by EMF. This is a low number and sustainable payout ratio.
DP25.4%
EPS Next 2YN/A
EPS Next 3YN/A
EMF Yearly Income VS Free CF VS DividendEMF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
EMF Dividend Payout.EMF Dividend Payout, showing the Payout Ratio.EMF Dividend Payout.PayoutRetained Earnings

More info and screens

TEMPLETON EMERGING MARKETS

NYSE:EMF (10/10/2025, 9:23:03 PM)

16.41

-0.61 (-3.58%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners67.85%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap246.64M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield 6.94%
Yearly Dividend0.72
Dividend Growth(5Y)-1.59%
DP25.4%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-18 2025-09-18 (0.22)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.08
Fwd PE N/A
P/S 34.21
P/FCF 8.06
P/OCF 8.06
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)2.03
EY12.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.04
FCFY12.41%
OCF(TTM)2.04
OCFY12.41%
SpS0.48
BVpS14.93
TBVpS14.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.19%
ROE 13.66%
ROCE 1.77%
ROIC 1.4%
ROICexc 1.4%
ROICexgc 1.4%
OM 56.73%
PM (TTM) 424.27%
GM 58.67%
FCFM 424.41%
ROA(3y)-5.09%
ROA(5y)2.7%
ROE(3y)-6.26%
ROE(5y)2.34%
ROIC(3y)1.66%
ROIC(5y)1.2%
ROICexc(3y)1.66%
ROICexc(5y)1.2%
ROICexgc(3y)1.66%
ROICexgc(5y)1.2%
ROCE(3y)2.1%
ROCE(5y)1.52%
ROICexcg growth 3Y54.93%
ROICexcg growth 5Y8.19%
ROICexc growth 3Y54.93%
ROICexc growth 5Y8.19%
OM growth 3Y31.34%
OM growth 5Y5.57%
PM growth 3Y-20.37%
PM growth 5YN/A
GM growth 3Y28.08%
GM growth 5Y5.26%
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 100.03%
Current Ratio 2.87
Quick Ratio 2.87
Altman-Z 20.67
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.96%
EPS 3Y-15.17%
EPS 5YN/A
EPS Q2Q%26.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.25%
Revenue growth 3Y4.04%
Revenue growth 5Y-1.1%
Sales Q2Q%-8.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.16%
EBIT growth 3Y36.66%
EBIT growth 5Y4.41%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y395.95%
FCF growth 3Y-17.15%
FCF growth 5YN/A
OCF growth 1Y395.95%
OCF growth 3Y-17.15%
OCF growth 5YN/A